Singapore markets closed

Aviva plc (AIVAF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
6.350.00 (0.00%)
At close: 09:30AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close6.35
Open6.35
Bid0.00 x 0
Ask0.00 x 0
Day's range6.35 - 6.35
52-week range4.48 - 6.35
Volume100
Avg. volume242
Market cap17.308B
Beta (5Y monthly)0.91
PE ratio (TTM)13.51
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield0.42 (6.59%)
Ex-dividend date11 Apr 2024
1y target estN/A
  • Reuters

    RPT-UK competition regulator decides against in-depth probe of Aviva, AIG Life UK merger

    Britain's competition regulator said on Thursday that it has decided not to open an in-depth 'phase 2' investigation into Aviva's acquisition of AIG Life UK. Britain's Aviva agreed last September to buy the UK life insurance business of U.S. insurer AIG, known as AIG Life UK, for 460 million pounds ($580.43 million). The transaction was expected to add 1.3 million individual protection customers and 1.4 million group protection members to Aviva's business, the UK insurer said at the time.

  • Reuters

    UK competition regulator decides against in-depth probe of Aviva, AIG Life UK merger

    Britain's competition regulator said on Thursday that it has decided not to open an in-depth 'phase 2' investigation into Aviva's acquisition of AIG Life UK. Britain's Aviva agreed last September to buy the UK life insurance business of U.S. insurer AIG, known as AIG Life UK, for 460 million pounds ($580.43 million). The transaction was expected to add 1.3 million individual protection customers and 1.4 million group protection members to Aviva's business, the UK insurer said at the time.

  • Reuters

    Aviva sells Singlife joint venture stake for $1.2 billion

    LONDON (Reuters) -Aviva has completed the sale of its stake in Singapore Life Holdings, plus two debt instruments, for a combined 937 million pounds ($1.19 billion), the British insurer said in a statement on Monday. Aviva announced in September that its 25.9% stake and the two debt instruments would be sold to Sumitomo Life. Aviva Chief Executive Amanda Blanc said in September that the transaction would simplify the business and put the company in a strong position to build on its trading momentum in the UK, Ireland and Canada.